Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
2 hedge funds and large institutions have $91 invested in Bionano Genomics, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
31% less capital invested
Capital invested by funds: $132 → $91 (-$41)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$203 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$113 |
BNGOW Hedge Fund Activity: Q2 2023 in Review
2 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q2 2023, worth a combined $91 — down 31% from $132 a quarter earlier.
Fund positioning in BNGOW was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was LMR Partners, opening a new position worth an estimated $203. The largest seller was UBS Group, exiting entirely with an estimated $113 sold.
- 2 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $91 of Bionano Genomics, Inc. Warrant stock for Q2 2023, down 31% quarter-over-quarter.
- 1 fund opened new Bionano Genomics, Inc. Warrant positions in Q2 2023 and 1 closed out, a net change of 0 holders.
- The largest Bionano Genomics, Inc. Warrant buyer in Q2 2023 was LMR Partners, an estimated $203 added.
- The largest Bionano Genomics, Inc. Warrant seller in Q2 2023 was UBS Group, an estimated $113 sold.
Based on aggregated 13F filings for Q2 2023.